New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:12 EDTHRTXHeron Therapeutics reports Q4 EPS (75c), consensus (53c)
The company said "Net loss was higher in the FY13 quarter primarily due to increased spending related to manufacturing development expenses and higher personnel costs, including stock compensation expense."
News For HRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
08:41 EDTHRTXHeron Therapeutics price target raised to $33 from $25 at JMP Securities
After meeting with Heron's management, JMP Securities believes that momentum is building for the company's acute pain program. The firm expects data slated to be announced next quarter to eliminate the program's risk. It keeps an Outperform rating on the shares.
June 26, 2015
10:00 EDTHRTXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:43 EDTHRTXHeron Therapeutics initiated with an Outperform at Cowen
Target $40.
June 19, 2015
07:52 EDTHRTXHeron Therapeutics price target raised to $38 from $26 at Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use